Articles by Stephen Israel - Pharmaceutical Executive

ADVERTISEMENT

Articles by Stephen Israel

Is There Life After Big Pharma?

Apr 1, 2005

You can have a biotech company with a great technology base, but if it doesn't have a product in Phase II development, Wall Street won't reward the company by increasing the value of its stock price. When products are valued over technology, there is a higher premium for commercially-focused business leaders.

ADVERTISEMENT

Click here